Changes in percutaneous coronary intervention practice in Japan during the COVID-19 outbreak: LIFE Study.
Changes in percutaneous coronary intervention practice in Japan during the COVID-19 outbreak: LIFE Study.
复制标题
DOI：
10.1002/ams2.638
复制
发表时间：
2021-01
影响因子：
1.6
通讯作者：
Kitamura T
中科院分区：
文献类型：
--
作者：
Maeda M;Fukuda H;Kiyohara K;Miki R;Kitamura T
冠状病毒病（COVID - 19）的全球爆发对临床实践产生了广泛影响，据报道，美国和意大利的经皮冠状动脉介入治疗（PCI）率下降。本研究旨在确定COVID - 19疫情对日本PCI实践的影响。在对日本神户市国民健康保险和晚期老年医疗保健系统参保者索赔数据的回顾性分析中，我们检查了COVID - 19爆发前和期间PCI发病率的变化。采用泊松回归分析，将2020年COVID - 19疫情期间的经皮冠状动脉介入治疗发生率与2019年同期（疫情前）的发生率进行比较，并以pci月数量为因变量。2020年2月至5月，神户市共有639名患者接受了PCI。结果显示，与爆发前相比，爆发期间所有PCI手术减少了19% （P = 0.001）。急性冠脉综合征（ACS）患者的非选择性pci无显著变化，但非ACS患者的选择性pci减少了25% （P < 0.001）。在日本，COVID - 19的爆发与非ACS病例的选择性pci下降有关，但似乎没有影响ACS病例的非选择性pci。COVID - 19的全球爆发对临床实践产生了深远的影响，据报道与美国和意大利经皮冠状动脉介入治疗（PCI）率的降低有关。我们使用神户市的索赔数据检查了COVID - 19爆发期间PCI发病率的变化。包括STEMI和非STEMI病例在内的急性冠脉综合征（ACS）没有显著变化，但非ACS病例的pci降低了23% （P<0.001）。
The global outbreak of coronavirus disease (COVID‐19) has had widespread effects on clinical practice, and is reportedly associated with reduced percutaneous coronary intervention (PCI) rates in the US and Italy. This study aimed to ascertain the influence of the COVID‐19 outbreak on PCI practice in Japan. In a retrospective analysis of claims data from National Health Insurance and Later‐Stage Elderly Healthcare System enrollees in Kobe City, Japan, we examined the changes in PCI incidence before and during the COVID‐19 outbreak. Percutaneous coronary intervention incidence during the COVID‐19 outbreak in 2020 was compared with that of the same (pre‐outbreak) period in 2019 using a Poisson regression analysis with the monthly number of PCIs as the dependent variable. A total of 639 patients underwent PCI in Kobe City between February and May 2020. The results showed a 19% reduction in all PCI procedures during the outbreak relative to the pre‐outbreak period (P = 0.001). There were no significant changes in non‐elective PCIs for acute coronary syndrome (ACS) cases, but a 25% reduction in elective PCIs for non‐ACS cases (P < 0.001). The COVID‐19 outbreak was associated with a decline in elective PCIs for non‐ACS cases, but did not appear to influence non‐elective PCIs for ACS cases in Japan. The global outbreak of COVID‐19 has had profound and far‐reaching effects on clinical practice, and is reported to be associated with a reduction in percutaneous coronary intervention (PCI) rates in the US and Italy. We examined the changes in PCI incidence during the COVID‐19 outbreak using claims data from Kobe City. There was no significant changes in Acute coronary syndrome (ACS) including STEMI and non‐STEMI cases, but a 23% reduction in PCIs for non‐ACS cases (P<0.001).
登录
查看更多内容
影响因子：
158.5
作者：
Boden, William E.;O'Rourke, Robert A.;Mathien, J.
通讯作者：
Mathien, J.
影响因子：
24
作者：
Inohara, Taku;Kohsaka, Shun;Nakamura, Masato
通讯作者：
Nakamura, Masato
影响因子：
168.9
作者：
Mafham, Marion M.;Spata, Enti;Baigent, Colin
通讯作者：
Baigent, Colin
影响因子：
3.3
作者：
Ishii, Hideki;Amano, Tetsuya;Ikari, Yuji
通讯作者：
Ikari, Yuji
影响因子：
2.8
作者：
Kim, Luke K.;Feldman, Dmitriy N.;Wong, S. Chiu
通讯作者：
Wong, S. Chiu